Resveratrol is not a new thing in the market of plant-functional raw materials. It was once as hot as curcumin at least, and its effect on life extension has attracted the attention of a lot of scientific researchers.

Resveratrol is thought to balance the rates of bone formation and resorption (bone loss). Bone resorption rates are higher than bone formation rates due to aging and obesity-related low levels of inflammation and menopausal hormonal changes, leading to a decrease in bone mineral density. Resveratrol stimulates the production of new bone-forming cells. Resveratrol's bone health benefits haven't received much attention, so bone health is a relatively new area of research.

The benefits of resveratrol in regulating blood sugar are also a promising area of research, though there are still some gaps. The company notes that recent comprehensive analyses have shown that resveratrol reduces fasting glucose, insulin, and insulin resistance in patients with type 2 diabetes. In addition, studies have shown that resveratrol can improve cardiovascular health in diabetics, such as helping to maintain healthy blood pressure.

The study indicates that the resveratrol sector will help activate the resveratrol market by adopting a strategy of simultaneous scientific research and formulation/carrier system applications. Resveratrol has actually grown in the last three years. Resveratrol is increasingly considered by customers to be one of the key ingredients to focus on if antioxidant products are developed. As more and more scientific research confirms, resveratrol is no longer a stand-alone ingredient in formulations but is becoming an essential ingredient.